*Salmonella enterica* Serovar Typhimurium Infection
===================================================

Non-typhoidal serovars of *Salmonella enterica* (NTS) are leading causes of foodborne illness and diarrheal disease worldwide ([@B95]; [@B248]; [@B212]; [@B9]; [@B115]; [@B123]). In the United States, NTS infections result in more hospitalizations and deaths compared to infections caused by any other foodborne pathogen ([@B212]). Among NTS, serovar Typhimurium (*S.* Tm) is one of the most commonly isolated from patients around the globe ([@B83]). NTS infections typically present as a self-limiting diarrheal disease ([@B2]; [@B94]); however, NTS gastrointestinal infections can develop into systemic disease in immunocompromised patients, as well as a small subset of immunocompetent patients ([@B2]; [@B94]). Currently, there are no effective vaccines against gastrointestinal infections. Additionally, treatment options are limited because antibiotics may lead to increased levels of *S.* Tm shedding and also because *S.* Tm is developing resistance to many antibiotics ([@B254]; [@B151]; [@B60]; [@B93]; [@B233]). Accordingly, alternative therapeutic intervention strategies are needed.

*S.* Tm establishes infection in the gastrointestinal tract and causes acute gastroenteritis. A common feature of *S.* Tm disease is inflammatory diarrhea indicated by the presence of neutrophils in patient stool samples ([@B104]). Type III secretion systems (T3SSs) are molecular syringe-like structures that allow Gram-negative organisms to directly inject effector proteins into the cytosol of host cells ([@B57]). *S.* Tm uses a T3SS encoded within *Salmonella* Pathogenicity Island (SPI) 1 (T3SS-1) to actively invade epithelial cells, induce inflammation, and breach the epithelial barrier ([@B81]; [@B238]). After exiting the intestinal tract, *S.* Tm is phagocytosed by resident and recruited immune cells, including macrophages. *S.* Tm utilizes the SPI-2 encoded T3SS (T3SS-2) to survive and replicate within these phagocytes ([@B108]; [@B176]; [@B217]). The cumulative effects of T3SS-2 cause unchecked bacterial replication during systemic infection and lethal disease ([@B257]).

Decades of research has identified a vast repertoire of *S.* Tm virulence determinants (extensively reviewed in [@B73]). Recent studies have expanded our understanding of factors that influence virulence gene expression, including growth phase and environmental signals ([@B125]; [@B224]); however, less is known about the signal transduction pathways that link environmental signals to virulence gene expression. In this review, we discuss recent findings concerning strategies that *S*. Tm uses to overcome microbiota- and host-derived obstacles within the intestinal and intramacrophage environments. Additionally, we highlight signals that *S.* Tm uses to coordinate expression of virulence genes required for adaptation to these distinct environments.

Making Room Within the Crowded Intestinal Tract
===============================================

The gastrointestinal tract is home to billions of microbes termed the microbiota. Interactions between the host, the microbiota, and pathogens have profound impacts on infection ([@B258]; [@B154]; [@B19]; [@B86]; [@B121]; [@B153]). The microbiota function as a barrier to limit pathogen colonization and shedding ([@B70]), an ability collectively referred to as colonization resistance. Colonization resistance is largely attributed to the ability of the microbiota to outcompete invading pathogens for nutrients; however, the microbiota can also modulate host mucosal immune responses important for clearing infection ([@B70]; [@B236]). Dysbiosis, or alterations to the microbiota, creates a non-competitive niche in which *S.* Tm is able to establish infection and rapidly replicate in the intestine. Antibiotic use results in disruptions to the microbiota and is a key risk factor associated with the *Salmonella*-associated diarrhea ([@B2]; [@B94]).

Although antibiotic-related dysbiosis provides an opening for *S.* Tm to establish infection, *S*. Tm also directly perturbs the microbiota to enhance and prolong infection (**Figure [1A](#F1){ref-type="fig"}**). *S.* Tm relies primarily on the T3SS-1, and to an extent the T3SS-2, to induce host inflammation, and the resulting innate immune response non-specifically targets the microbiota along with *S*. Tm ([@B17]; [@B48]; [@B226]; [@B16]; [@B131]; [@B215]; [@B114]; [@B128]; [@B65]; [@B200]). As a result of T3SS-induced inflammation, a proportion of infecting *S.* Tm cells succumb to host immune responses; however, a sufficient amount of *S.* Tm cells survive to successfully establish infection ([@B189]; [@B139]; [@B27]; [@B147]; [@B61]). Several environmental conditions contribute to T3SS-1 expression ([@B91]). For example, oxygen limitation and high salt concentrations enhance SPI-1 expression and epithelial cell invasion ([@B82]; [@B132]; [@B14]; [@B162]), whereas bile and some long and short chain fatty acids, such as a butyrate, oleate, myristate, and palmitate, repress T3SS-1 expression ([@B187]; [@B130]; [@B84]; [@B66]; [@B90]). The balance of activating and repressing signals is thought to enrich *S.* Tm invasion in the ileum *in vivo* ([@B130]; [@B84]; [@B66]). Expression of the T3SS-1 is regulated by a feed-forward loop in which the regulatory proteins HilD, HilC, and RtsA positively control expression of the master transcription factor HilA ([@B13]; [@B68]). HilD, HilC, and RtsA are transcription factors that bind to the *hilA* promoter to induce *hilA* expression ([@B213]; [@B178]; [@B69]). HilA then activates the expression of the remaining transcription factors and structural components of the T3SS-1, as well as non-SPI-1-encoded effectors ([@B184]). Expression of the T3SS-1 core regulatory system is in turn regulated by accessory factors that are presumed to respond to environmental signals ([@B91]), but how these signals are incorporated into the SPI-1 regulatory pathway has not been fully elucidated.

![*S.* Tm overcomes microbiota-mediated colonization resistance in the intestinal tract. **(A)** The cumulative effects of T3SS-1/T3SS-2-induced inflammation lead to robust colonization of the intestinal tract and efficient transmission to a new host. **(B)** *S.* Tm utilizes the T3SS-1 and T3SS-2 to generate a robust host immune response within the intestinal tract to eliminate members of the microbiota. **(C)** T3SS-1/T3SS-2-induced inflammation leads to the production of metabolites such as electron acceptors including oxygen, nitrate, and tetrathionate that promote aerobic and anaerobic respiration. T3SS, type III secretion system; T6SS, type VI secretion system.](fmicb-08-01983-g001){#F1}

Besides causing unspecific disruption to the microbiota as a whole, *S.* Tm-induced inflammation impacts particular intestinal microbes that alter concentrations of metabolites and/or host responses that would otherwise limit *S*. Tm infection (**Figure [1B](#F1){ref-type="fig"}**). For example, *S.* Tm infection induces RegIIIβ expression, and RegIIIβ is directly bactericidal against *Bacteroides* sp. and *Eubacterium rectale* ([@B160]). RegIII lectin family proteins are expressed in the intestinal tract and are important for maintaining intestinal homeostasis and combating pathogens ([@B39]; [@B241]; [@B161]). Suppression of *Bacteroides* sp. is associated with changes in metabolite availability in the gut, most notably a decrease in vitamin B6 concentrations ([@B160]). Significantly, reconstitution of *Bacteroides* or supplementation of vitamin B6 contributes to the resolution of *S.* Tm infection, further underscoring the complex interplay of host, bacteria, and metabolites ([@B160]). *S.* Tm T3SS-1 and T3SS-2-induced inflammation also leads to depletion of *Clostridia* sp. in the intestine, which enhances *S.* Tm colonization ([@B200]) (detailed in the next section). The host factor that directly depletes *Clostridia* sp. has not been identified.

Additionally, commensal *Escherichia coli* represents a minor component of the microbiota during homeostasis, but during general dysbiosis, the proportion of *E. coli* within the bacterial community increases ([@B253]). *E. coli* and *S*. Tm compete for metabolites and deploy molecules to limit growth of each other ([@B189]; [@B58]; [@B211]). For example, iron is an essential nutrient for most microbes and is typically limited within the host; therefore, microbes have evolved mechanisms to scavenge iron ([@B22]). *E. coli* and *S*. Tm produce and secrete siderophores, which are small molecules that chelate iron ([@B51]; [@B22]). *E. coli* siderophores can be conjugated to microcins, small antibacterial peptides that kill bacterial cells through an unknown mechanism ([@B198]; [@B211]). To fight back, the *S.* Tm T3SS-1 and T3SS-2 promote expression of the chemokine IL-22, which results in the production of antimicrobials that kill *E. coli* but are ineffective against *S.* Tm ([@B89]; [@B189]; [@B229]; [@B139]; [@B20]). By inducing IL-22, *S*. Tm eliminates Enterobacteriaceae species and thus direct nutritional competitors.

*S.* Tm also takes direct action against competitors using a type VI secretion system (T6SS). T6SSs are commonly found in the Proteobacteria and Bacteroidetes phyla and are structurally homologous to bacteriophage tail complexes ([@B28]; [@B205]; [@B110]). These dynamic structures contract to directly inject effector proteins into target cells ([@B18]). Although T6SS can inject effector proteins into host cells ([@B145]; [@B214]), increasing evidence suggest that T6SSs primarily target and cause subsequent death of bacterial cells ([@B169]; [@B188]; [@B24]; [@B45]). The T6SS encoded by *S.* Tm has selective bactericidal efficacy against commensal organisms *in vitro*, including other members of the Enterobacteriaceae, such as *E. coli* W3110, *Klebsiella oxytoca*, and *Klebsiella variicola* ([@B37]; [@B208]). However, *Enterobacter cloacae* and *E. coli* JB2 are resistant to *S.* Tm T6SS attack ([@B208]). It is currently unclear why different species are susceptible or resistant. The efficacy of the *S*. Tm T6SS against *K. oxytoca* data were validated *in vivo* during intestinal co-infection studies ([@B208]). These data support an important role for the *S*. Tm T6SS against other members of the microbiota; however, the benefits of selective killing remain to be defined. A better understanding of the commensal organisms that are directly targeted by *S.* Tm via the T6SS *in vivo* may reveal essential metabolites that are being differentially regulated that may impact *S.* Tm growth or virulence gene expression.

Collectively, these findings reveal that a central strategy *S.* Tm uses to colonize the host is to actively displace members of the microbiota. *S*. Tm achieves this through manipulation and exploitation of host responses ([@B226]; [@B165]). Moreover, *S*. Tm is capable of directly eliminating particular bacterial species. This transforms the intestinal tract into an environment that *S.* Tm is optimized to survive in and ultimately lowers the barrier of colonization resistance.

Metabolism in the Face of Inflammation
======================================

Dysbiosis not only results in changes in the bacterial populations but also changes the chemistry of the intestine ([@B260]). Hence, a second aspect of *S.* Tm infection includes exploiting nutrients generated specifically during infection. The majority of bacteria that comprise the microbiota are obligate anaerobes that rely on fermentation for growth ([@B87]). Enterobacteriaceae, including *S.* Tm, are able to gain energy by respiration. Respiration generates higher amounts of ATP compared to fermentation and thereby enables *S*. Tm to outgrow many members of the microbiota ([@B251]; [@B32]; [@B150]; [@B148]; [@B173]; [@B253]; [@B260]) (**Figure [1C](#F1){ref-type="fig"}**). During homeostasis, host colonocytes consume oxygen, yielding a localized environment characterized by low oxygen partial pressure ([@B38]; [@B71]). Colonocytes preferentially oxidize short-chain fatty acids, such as butyrate, to respire oxygen ([@B99]; [@B62]; [@B119]). Because *Clostridia* are the major producers of butyrate in the intestine, depletion of *Clostridia* with antibiotics or during *S*. Tm infection leads to a concomitant decrease in oxygen consumption by colonocytes ([@B215]; [@B143]; [@B88]; [@B247]; [@B200]). *S.* Tm capitalizes on newly available oxygen to rapidly grow within the intestine ([@B200]). These findings reveal a complex role for oxygen during infection. On the one hand, low levels of oxygen enhance SPI-1 expression, leading to increased inflammation and subsequent restriction of commensal organisms such as *Clostridia*. On the other hand, newly available oxygen promotes growth within the intestine. Oxygen limitation might therefore allow *S.* Tm to regulate the kinetics of SPI-1 expression within the intestine. In this proposed model, oxygen limitation early on during infection would promote SPI-1 expression, which would then in turn deplete commensal *Clostridia* via the host immune response, which would then result in an increase in oxygen availability leading to *S.* Tm outgrowth and subsequent reduction in SPI-1 expression. Additionally, the decrease in butyrate availability may also restrict the abundance of butyrate metabolizing members of the microbiota leading to even greater levels of dysbiosis.

The electron acceptors nitrate and tetrathionate also support *S*. Tm growth during infection ([@B252]; [@B142], [@B141]). The T3SS-1-secreted effector SopE is a bacteriophage-encoded activator of host Rho GTPases that results in host cytoskeletal rearrangements and activation of immune signaling pathways ([@B103]). Additionally, SopE induces expression of host inducible nitric oxide synthase (iNOS) and generates nitrate ([@B142]). Tetrathionate generation is a two-step process. Microbiota-produced hydrogen sulfide is converted by host colonocytes to thiosulfate, which reacts with oxygen radicals produced by host NADPH oxidase to generate tetrathionate ([@B252]). Tetrathionate reduction is coupled to ethanolamine, 1,2-propanediol, or fructose-asparagine oxidation ([@B185]; [@B237]; [@B3]; [@B206]; [@B72]). Ethanolamine is a component of phosphatidylethanolamine, one of the most abundant phospholipids in host and microbial membranes ([@B190]; [@B54]). The turnover of enterocytes and microbial cells as well as the diet provide a continuously replenished source of ethanolamine in the intestine ([@B50]; [@B117]; [@B63], [@B64]; [@B221]; [@B15]). The accumulation of 1,2-propanediol depends primarily on the microbiota. It is thought that the ability of *Bacteroides* sp. to breakdown complex carbohydrates allows for the production of 1,2-propanediol as a byproduct of fermentation of methyl-pentoses ([@B72]), although experiments are needed to demonstrate this during the course of infection. This model is supported by the findings that 1,2-propanediol is nearly undetectable in germ-free mice; however, the presence of either *Bacteroides fragilis* or *Bacteroides thetaiotaomicron* is associated with 1,2-propanediol accumulation ([@B72]). Additionally, expression of *S*. Tm genes coding for 1,2-propanediol metabolism are induced in the presence of *B. thetaiotaomicron in vivo* ([@B173]; [@B72]). Furthermore, the presence of *B. thetaiotaomicron* within the intestinal tract enhances *S.* Tm expression of additional carbohydrate metabolism and transport genes, including sialic acid and fucose catabolic pathways ([@B173]). The *B. thetaiotaomicron*-encoded sialidase liberates sialic acid, which promotes *S.* Tm sialic acid metabolism and intestinal growth ([@B173]). These data indicate a somewhat paradoxical relationship between *S.* Tm and *Bacteroides* sp. As discussed above, *S.* Tm-induced inflammation restricts the levels of *Bacteroides* sp. ([@B160]) and yet *Bacteroides* sp. are critical for the accumulation of multiple metabolites that *S*. Tm utilizes during infection ([@B173]; [@B72]). These seemingly conflicting ideas suggest an even more complex relationship between pathogen and microbiota. Rather than presence or absence of commensals, *S.* Tm may require a fine-tuned abundance of microbes to generate beneficial metabolites without these organisms directly competing with *S.* Tm.

*S.* Tm also exploits electron acceptors as spatiotemporal cues for colonization and tissue invasion. Nitrate and tetrathionate are indirect signals for *S.* Tm chemotaxis and thereby influence subsequent stages in *S*. Tm infection ([@B201]). The chemotaxis proteins Aer and Tsr sense changes in redox and proton motive force during tetrathionate and nitrate respiration, respectively ([@B67]; [@B199]). Both Aer and Tsr promote T3SS-1/T3SS-2-dependent intestinal colonization ([@B201]). Tsr-dependent chemotaxis correlates with localized host production of iNOS and enables *S.* Tm to invade ileal Peyer's patches ([@B199]). Surprisingly, no additive effect is seen with Aer and Tsr-dependent chemotaxis ([@B201]). This suggests that these two sensing pathways may be interconnected and perhaps functionally redundant. Connectivity of these two pathways is further supported by the observation that the presence of nitrate reduces the expression of genes involved in tetrathionate respiration as well as the growth advantage conferred by tetrathionate respiration ([@B142]). It is currently unclear how *S*. Tm balances the sensing and utilization of two signals that may restrict one another.

Much of our understanding of the host--microbiota--pathogen interplay has been generated through genetic manipulation of the pathogen, and alternative experimental approaches are shedding new light on this interaction. For example, defined commensal communities have been used to reconstitute the microbiota of germ-free mice and study the contributions of specific members of the microbiota necessary for effective colonization resistance ([@B59]; [@B225]; [@B35]). Studies using defined microbial communities will also contribute to understanding how differences in microbial species between susceptible and resistant intestinal environments impact *S.* Tm virulence gene expression. Additionally, a recent RNA-seq study assessed gene expression in *S*. Tm grown under 22 different *in vitro* conditions that mimicked aspects of infection, which could reveal new signals important for controlling the expression of key metabolic and virulence determinants ([@B125]). Future *in vivo* metabolomics studies may identify specific microbiota or diet-dependent molecules that impact *S.* Tm virulence gene expression and/or host response. In line with this, a high salt diet was recently identified as significantly altering the host response during *S.* Tm infection ([@B239]). Thus, the ability to manipulate commensal microbial communities and intestinal metabolite concentrations offers an exciting tool to further understand how microbiota and metabolites not only impact *S*. Tm growth but also impact *S*. Tm virulence.

Collectively, these findings highlight that *S.* Tm thrives during host dysbiosis, benefits from the host immune response, and utilizes virulence factors to directly and indirectly suppress members of the microbiota. However, *S.* Tm relies on members of the indigenous microbial community to expand its metabolic capabilities during infection that in turn promote outgrowth and transmission ([@B148]). Although some host factors and cytokines that are involved in the development of inflammation during infection are known ([@B21]), additional components are likely to contribute to *S.* Tm infection. A more comprehensive understanding of immune responses that contribute to dysbiosis and/or generate a nutritional niche for *S.* Tm is necessary to fully understand *S.* Tm infection strategies, and indeed, this remains an active area of research. Host inflammatory components could be enhancing intestinal pathology, restricting microbiota reconstitution, molding a new nutrient niche, or enhancing all aspects of infection.

Intramacrophage Adaptation
==========================

After benefiting from components of the host immune response during intestinal colonization, *S.* Tm must withstand the bactericidal efforts of host phagocytes during systemic infection. *S.* Tm dissemination from the intestinal tract to systemic sites of infection largely depends on phagocytic cells ([@B246]). Of the host phagocytes, macrophages frequently interact with *S.* Tm during dissemination and within systemic sites, including the spleen and liver ([@B207]). Macrophages utilize several strategies such as acidification of phagosomes, generation of reactive oxygen and nitrogen species, and production of antimicrobial proteins and peptides to kill internalized pathogens ([@B78]); however, *S.* Tm is able to withstand these defense mechanisms through multiple molecular mechanisms. The T3SS-2 and associated secreted effectors create a replicative niche within macrophages termed the *Salmonella* containing vacuole (SCV) by modulating diverse host processes ([@B108]; [@B176]; [@B217]; [@B75]). For example, these effectors inhibit SCV--lysosome fusion, modify host vesicle trafficking, localize the SCV within the cell, and evade the host autophagic response ([@B240]; [@B219]; [@B96]; [@B29]; [@B36]; [@B112]; [@B181], [@B180]). Multiple environmental signals and bacterial regulators influence this critical adaptation step (discussed below).

Counteracting Host Defense Mechanisms
=====================================

Pathogen recognition is the first line of defense for phagocytic cells such as macrophages. Host Toll-like receptors (TLRs) are transmembrane proteins located on the plasma membrane and endosomal membranes that recognize conserved molecular patterns associated with pathogens such as lipids, proteins, and nucleic acids ([@B118]). TLRs have profound impacts on adaptive immunity and are thus broadly essential for host defense ([@B111]). Additionally, TLRs are critical for control of *S.* Tm replication as well as host survival during infection ([@B249]). TLR activation and downstream signaling through the adapter proteins MyD88 and TRIF is linked to initial SCV acidification ([@B11]). The SCV acidifies rapidly following phagocytosis, dropping to a pH between 4.0 and 5.0 within 60 min of formation ([@B193]). Acidification of the SCV is essential for *S.* Tm expression and functional formation of the T3SS-2 as well as secretion of effectors ([@B193]; [@B23]; [@B102]; [@B191]; [@B11]; [@B40]). Thus, *S.* Tm co-opts part of the macrophage defense system to serve as an initiating signal that promotes bacterial survival.

In the host, concentrations of free iron are extremely low in part to limit growth of invading pathogens ([@B127]; [@B22]). For example, the host expresses iron regulatory proteins (IRPs) and lipocalin-2 to limit the amount of iron available within macrophages ([@B127]; [@B170],[@B171]). Host-mediated iron limitation significantly restricts *S.* Tm replication within macrophages and reduces lethal disease ([@B170]). Additionally, IRP and lipocalin-2 influence the immune response during *S.* Tm infection ([@B170],[@B171]). Indeed, modulating the immune response, specifically interleukin 10, can rescue the bactericidal defects of lipocalin-2 deficient cells and mice ([@B171]). These results suggest that host iron concentrations indirectly affect *S.* Tm survival through alteration of the host immune response rather than by directly starving *S.* Tm of iron. Nonetheless, modulation of iron concentrations does influence *S.* Tm expression of virulence genes. For example, SPI-2 expression is reduced when *S.* Tm is grown in the presence of iron ([@B44]; [@B43]), and the iron-sensing transcription factors Fur and PmrA limit SPI-2 expression during macrophage infection ([@B255]; [@B44]; [@B43]). However, SPI-2 expression has also been shown to be reduced when iron is chelated from cultures and during infection of macrophages that have low iron concentrations ([@B259]; [@B172]). These contrasting findings require further investigation. Similarly, it is unclear what the iron availability is within the SCV with and without host iron acquisition mediators IRP and lipocalin-2.

Altogether, these findings highlight that *S.* Tm senses and responds to macrophage defense mechanisms, which impact *S.* Tm virulence and survival. By utilizing host defenses as signals, *S.* Tm incorporates antimicrobial processes into a bacterial signal transduction pathway that creates a suitable replication niche in an otherwise inhospitable environment.

Intramacrophage Sensing and Signaling
=====================================

In addition to host defense-linked signals, *S.* Tm responds to concentrations of cations, nutrients, and ATP to activate expression of SPI-2 and other virulence factors to ensure survival ([@B242]; [@B46]; [@B56]; [@B122]; [@B140]; [@B179]; [@B134]; [@B25]) (**Figure [2](#F2){ref-type="fig"}**). To sense these environmental signals and regulate SPI-2 expression, *S.* Tm uses several two-component systems (TCS) ([@B74]). TCS are typically comprised of a sensor kinase that autophosphorylates upon sensing of a stimulus and then phosphorylates its paired response regulator, which in turn binds DNA to activate transcription of target genes ([@B231]). The PhoPQ TCS senses acidic pH, divalent cations, antimicrobial peptides, and potentially other signals to activate SPI-2 expression and modify components of the bacterial outer membrane ([@B12]; [@B186]; [@B53]; [@B109]). In addition to SPI-2, PhoP regulates other virulence factors, including the *mgtCBR* operon. The *mgtCBR* operon encodes an inner membrane protein, a Mg^2+^ transporter, and a regulator and is critical for intramacrophage survival ([@B222]; [@B26]; [@B4]; [@B133]). It is still unclear what host or bacterial factors contribute to the presence of these SPI-2 activating signals within the SCV.

![*S.* Tm senses environmental cues to adapt to the intramacrophage environment. **(A)** *S.* Tm recognizes diverse signals within the macrophage. These include iron limitation, ethanolamine, acidic pH, antimicrobial peptides, divalent cations, epinephrine/norepinephrine, and cellular ATP. These signals act to induce SPI-2 expression and establish the SCV as a replicative niche. **(B)** Schematic of some of the regulatory proteins and associated signals important for activating SPI-2 expression. Signals are written blue; regulatory proteins and TCS are written in red. TLRs, Toll-like receptors; SCV, *Salmonella* containing vacuole.](fmicb-08-01983-g002){#F2}

*S.* Tm also responds to signals that are not specific to the SCV, but rather are found in multiple environments throughout the host. For example, the host hormones epinephrine and norepinephrine (epi/NE) are ubiquitous throughout the body ([@B30]). The bacterial TCS QseBC and QseEF sense and respond to epi/NE during infection ([@B47]; [@B197]). The sensor kinase QseC regulates the expression of genes encoded within SPI-1 and enhances epithelial cell invasion under conditions that promote SPI-1 expression ([@B168]). Additionally, during macrophage infection, QseC activates SPI-2 expression to enhance intramacrophage survival ([@B168]). Moreover, both epi/NE-responsive histidine sensor kinases, QseC and QseE, are required for systemic infection ([@B192]; [@B168]; [@B167]). NE induces expression of both SPI-1 and SPI-2 associated genes, however, only expression of SPI-2 associated genes is QseC dependent ([@B168]). These findings reveal that the same signal (epi or NE) enhances *S.* Tm virulence gene expression depending on the surrounding environment. The additional components of the intramacrophage environment that allow these epi/NE-dependent signaling pathways to distinguish between a SPI-1 or SPI-2 inducing condition warrant further studies.

Ethanolamine is another signal that plays environment-dependent roles in expression of *S.* Tm virulence traits ([@B7]). Ethanolamine is present in serum and is maintained intracellularly by host cells in part to recycle and produce phosphatidylethanolamine ([@B174]; [@B137], [@B136]; [@B210]; [@B218]). In the Enterobacteriaceae, including *S.* Tm, the transcription factor EutR directly senses ethanolamine ([@B203]; [@B144]). EutR-dependent signaling promotes ethanolamine metabolism during intestinal infection ([@B8]). As infection progresses, ethanolamine promotes *S*. Tm dissemination to systemic sites independently of metabolism ([@B8]). Although ethanolamine metabolism does not provide a growth benefit for *S.* Tm during systemic infection ([@B232]; [@B237]; [@B227]; [@B8]), EutR directly activates expression of SPI-2 within macrophages leading to increased survival and early dissemination ([@B8]). It is currently unclear how ethanolamine can signal through the same receptor, EutR, to promote niche adaptation in distinct host environments. However, it is clear that ethanolamine plays a dual role in *S*. Tm infection by supporting growth in the inflamed intestine as well as enhancing subsequent stages of *S*. Tm disease.

The production of *Salmonella*-induced filaments (SIFs) is a critical component of *S.* Tm adaptation to intracellular environments ([@B85]; [@B228]). This SIF network remodels the host endosomal network, allowing *S.* Tm to gain access to endocytosed molecules ([@B177]; [@B138]). The SCV/SIF continuum is required for efficient intracellular metabolism and promotes *S.* Tm replication ([@B138]). While the focus of this study was on access to metabolites ([@B138]), the same principle of incorporating extracellular molecules into the SCV may be true for signaling molecules that promote virulence. In such a model, signaling molecules present within host endosomes, or recently endocytosed molecules from the extracellular environment, would be shuttled through the SCV/SIF continuum and potentially impact *S*. Tm virulence gene expression. This revelation opens the possibility that large sets of molecules within various host tissues are able to reach the SCV within macrophages *in vivo*. Additionally, genes that have previously been identified as not being induced during macrophage infection *in vitro* may be the result of a relevant signal being absent from the culture conditions. Determining *in vivo* signals that *S.* Tm recognizes remains a daunting challenge but is necessary for a thorough understanding of the events that trigger intracellular adaptation.

The majority of work on environmental signals and sensing within macrophages has focused on transcriptional regulation; however, recent proteomic and RNA-seq approaches have shown that regulation of gene expression is more complex. Post-translational modifications as well as small regulatory RNA (sRNA)-induced post-transcriptional changes regulate virulence during macrophage infection ([@B10]; [@B250]). sRNAs are non-coding 50--500 nucleotide transcripts that utilize base-pair interactions to post-transcriptionally regulate the expression of target mRNAs ([@B105]). *S.* Tm encodes approximately 300 unique sRNAs, and the expression of a subset of sRNAs is highly sensitive to signals encountered within the macrophage environment, such as nutrient starvation, and are controlled by key components of the SPI-2 regulatory system ([@B126], [@B125]; [@B6]; [@B49]). Specifically, the sRNA PinT regulates SPI-2 expression and is critical for host adaptation *in vivo* ([@B41]; [@B250]). It is possible that post-transcriptional regulation helps *S.* Tm incorporate environmental signals sensed within the SCV to modulate survival.

In addition to active intracellular replication, entering a non-replicating yet viable state is an alternative adaptation strategy. A portion of the infecting *S.* Tm population enters a persistent state within macrophages that is independent of SPI-2 ([@B107]). These non-replicating *S.* Tm remain viable and are not killed by macrophage antimicrobial defenses ([@B107]). This phenomenon has also been demonstrated within non-phagocytic cells *in vivo* ([@B175]). It is unclear how these persister cells impact disease progression *in vivo*, but perhaps persister cells promote asymptomatic carriage and transmission. Future studies are required to determine if there is transcriptional overlap between these persister cells and actively replicating *S.* Tm or if perhaps post-transcriptional regulation contributes to this phenotypic switch. Advancements in single cell expression techniques will allow replicating and dormant cells to be distinguished from one another. Similarly, it remains unclear what signals present within the SCV trigger the shift from replication to persistence. Although distinct signals may be responsible for transitioning to a persistent state, it is also possible that loss of the signals important for replication leads to dormancy.

Altogether, these studies reveal complex and dynamic regulatory circuits important for *S*. Tm survival within macrophages. *S.* Tm must appropriately repress and activate virulence gene expression to ensure adaptation to the SCV ([@B116]; [@B44]; [@B250]). Additionally, *S.* Tm must be able to initiate distinct regulatory pathways at different time points during infection ([@B168]; [@B167]; [@B8]). Further understanding of these activating and suppressing cues, and how they are balanced with one another, will enhance our understanding of *S.* Tm pathogenesis.

Host Cell Death
===============

The replication-suitable SCV within macrophages is a temporary niche, as host cells die. The way in which cells die has a tremendous impact on host physiology and inflammation ([@B183]; [@B155]). Programmed host cell death can be classified based on the effector proteins required and the state of inflammation each type of death induces ([@B124]). Three of the major programmed cell death pathways are apoptosis, necroptosis, and pyroptosis ([@B124]). *S.* Tm infection induces apoptosis-like features in infected macrophages including chromatin condensation and caspase-3 and caspase-8 activity ([@B42]; [@B135]; [@B164]; [@B243]; [@B149]; [@B97]). Additionally, *S.* Tm infection can induce RIPK3 and MLKL-dependent necroptosis ([@B202]; [@B97]). The best-characterized form of *S.* Tm-induced cell death is caspase-1/caspase-11-dependent pyroptosis ([@B31]; [@B163]; [@B77]; [@B76]). Host cells employ several means to recognize *S.* Tm virulence proteins and initiate regulated pyroptosis. For example, macrophage NLRC4 (Ipaf) recognizes *S.* Tm flagellin and components of T3SS-1 to activate caspase-1 ([@B79]; [@B157], [@B159]; [@B261]). Additionally, macrophage NAIP1 also recognizes components of T3SS-1 to initiate a pyroptotic death ([@B196]; [@B256]). Caspase-1 and caspase-11, as well as their activators NLRP3 and NLRC4, impact *S.* Tm pathogenesis and bacterial burden *in vivo* ([@B129]; [@B195]; [@B33], [@B34]). Interestingly, the host is able to enhance clearance of *S.* Tm infection when pyroptosis is experimentally induced *in vivo* ([@B158]; [@B230]; [@B1]; [@B113]). These findings suggest that *S.* Tm might try to evade inducing host cell death during some stages of infection. Although most commonly studied in macrophages, *S.* Tm-induced cell death also occurs in dendritic and epithelial cells ([@B244]; [@B216]; [@B194]). It remains uncertain if infected cells are simply overwhelmed by *S.* Tm over time *in vitro*, if *S.* Tm actively regulates virulence to promote or evade host cell death *in vivo*, if cell death is occurring throughout infection, and what the consequences of host cell death are during systemic disease.

Conclusion
==========

*S.* Tm is able to recognize, adapt to, and survive within the intestinal tract and the intramacrophage environment during infection. These two environments present very different obstacles to infection, and *S.* Tm utilizes diverse strategies to overcome these distinct barriers. A better understanding of the signaling molecules, the signal transduction pathways, and the cross talk between signal transduction pathways that promote niche recognition may provide novel opportunities for therapeutic intervention. Importantly, several of the strategies used by *S.* Tm to adapt to host environments are conserved among several organisms such as pathogenic *E. coli*, *Listeria monocytogenes*, *Brucella abortus*, and *Staphylococcus aureus*. For example, pathogens adapt to the host or regulate virulence by utilizing and/or sensing nitrate ([@B223]; [@B253]), epi/NE ([@B52]; [@B98]; [@B166]; [@B204]), ethanolamine ([@B146]; [@B120]; [@B55]; [@B92]; [@B156]; [@B235]), iron ([@B5]; [@B262]; [@B101], [@B100]; [@B152]; [@B182]), and pH ([@B106]; [@B234]; [@B220]; [@B245]). Additionally, T6SS are widely conserved, particularly within Proteobacteria and Bacteroidetes ([@B110]), and promote colonization of intestinal pathogens ([@B80]; [@B209]). Perhaps the fact that *S.* Tm utilizes all of these strategies, rather than a select few, makes *S.* Tm so successful and such a major burden on global healthcare ([@B212]). Therefore, further study of these environmental adaptation strategies, using *S.* Tm as a model organism, will enhance our understanding of the host--microbiota--pathogen interface.
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